TipRanks
Go Ultimate55% OFF

Compare Fennec Pharmaceuticals (FENC) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
FENCFennec Pharmaceuticals$10.26$359.09M-78.7722.93%Strong BuyUnlock the FENC analyst price target with TipRanks PremiumFENCUnlock the FENC top-analyst price target with TipRanks Premium
TSE:MSCLSatellos BioscienceCAD 9.32CAD 202.40M-3.466.00%Strong BuyUnlock the TSE:MSCL analyst price target with TipRanks PremiumFENC vs TSE:MSCLUnlock the TSE:MSCL top-analyst price target with TipRanks Premium
TSE:HBPHelix BioPharmaCAD 0.90CAD 75.61M-22.50-54.17%―Unlock the TSE:HBP analyst price target with TipRanks PremiumFENC vs TSE:HBPUnlock the TSE:HBP top-analyst price target with TipRanks Premium
TSE:EPRXEupraxia PharmaceuticalsCAD 9.33CAD 624.34M-6.7026.93%Strong BuyUnlock the TSE:EPRX analyst price target with TipRanks PremiumFENC vs TSE:EPRXUnlock the TSE:EPRX top-analyst price target with TipRanks Premium
TSE:METXME Therapeutics Holdings, Inc.CAD 1.10CAD 33.05M-23.81-78.00%―Unlock the TSE:METX analyst price target with TipRanks PremiumFENC vs TSE:METXUnlock the TSE:METX top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
FENCFennec Pharmaceuticals10.242.1125.95%
TSE:MSCLSatellos Bioscience9.540.181.92%
TSE:HBPHelix BioPharma0.99-1.12-53.08%
TSE:EPRXEupraxia Pharmaceuticals9.521.0512.40%
TSE:METXME Therapeutics Holdings, Inc.1.10-4.25-79.44%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts